Wuhan General Gr Stock Cash And Equivalents
WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Wuhan General Gr fundamentals help investors to digest information that contributes to Wuhan General's financial success or failures. It also enables traders to predict the movement of Wuhan Pink Sheet. The fundamental analysis module provides a way to measure Wuhan General's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wuhan General pink sheet.
Wuhan |
Wuhan General Gr Company Cash And Equivalents Analysis
Wuhan General's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Wuhan General Cash And Equivalents | 18.79 M |
Most of Wuhan General's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wuhan General Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Wuhan General Gr has 18.79 M in Cash And Equivalents. This is 97.71% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.3% higher than that of the company.
Wuhan Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wuhan General's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Wuhan General could also be used in its relative valuation, which is a method of valuing Wuhan General by comparing valuation metrics of similar companies.Wuhan General is currently under evaluation in cash and equivalents category among its peers.
Wuhan Fundamentals
Return On Equity | -0.0878 | ||||
Return On Asset | -0.005 | ||||
Profit Margin | (0.13) % | ||||
Operating Margin | (0.03) % | ||||
Current Valuation | 3.05 M | ||||
Shares Outstanding | 33.93 M | ||||
Number Of Shares Shorted | 12.62 K | ||||
Price To Earning | (0.06) X | ||||
Price To Book | 0.04 X | ||||
Price To Sales | 0.05 X | ||||
Revenue | 80.38 M | ||||
Gross Profit | 14.54 M | ||||
EBITDA | 379.92 K | ||||
Net Income | (10.59 M) | ||||
Cash And Equivalents | 18.79 M | ||||
Cash Per Share | 0.55 X | ||||
Total Debt | 118.8 M | ||||
Debt To Equity | 1.11 % | ||||
Current Ratio | 1.10 X | ||||
Book Value Per Share | 2.34 X | ||||
Cash Flow From Operations | (21.86 M) | ||||
Short Ratio | 0.15 X | ||||
Earnings Per Share | (0.35) X | ||||
Number Of Employees | 700 | ||||
Beta | 1.94 | ||||
Market Capitalization | 3.05 M | ||||
Total Asset | 286.58 M | ||||
Retained Earnings | 15 M | ||||
Working Capital | 18 M | ||||
Current Asset | 197 M | ||||
Current Liabilities | 179 M | ||||
Net Asset | 286.58 M |
About Wuhan General Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wuhan General Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wuhan General using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wuhan General Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Wuhan General
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.Moving together with Wuhan Pink Sheet
Moving against Wuhan Pink Sheet
0.72 | INIS | International Isotopes | PairCorr |
0.69 | YCBD-PA | cbdMD Inc | PairCorr |
0.67 | HROWM | Harrow Health, 11875 | PairCorr |
0.54 | ELTP | Elite Pharma | PairCorr |
0.38 | VAXX | Vaxxinity | PairCorr |
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |